Should the FDA Reconsider Antidepressant Black Box Warnings?

🔗 Access full article via Medscape Neurology

For nearly 20 years, antidepressants have carried suicide risk warnings for young people. Now, experts are questioning if the FDA should reconsider these warning labels.
Medscape Medical News